Clearmind Medicine Inc

CMND

Company Profile

  • Business description

    Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company’s intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

  • Contact

    101-1220 West 6th Avenue
    VancouverBCV6H 1A5
    CAN

    T: +1 604 260-1566

    https://www.clearmindmedicine.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 October 2025

    Employees

    1

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,579.5049.700.58%
CAC 407,853.4716.680.21%
DAX 4023,695.59168.580.72%
Dow JONES (US)42,322.75271.690.65%
FTSE 1008,633.7548.740.57%
HKSE23,278.09175.07-0.75%
NASDAQ19,112.3234.49-0.18%
Nikkei 22537,659.3996.12-0.25%
NZX 50 Index12,813.8366.99-0.52%
S&P 5005,916.9324.350.41%
S&P/ASX 2008,345.3047.800.58%
SSE Composite Index3,361.2219.60-0.58%

Market Movers